A cost-effectiveness analysis of stays in intensive care units

Abstract Objective: To evaluate patient outcome and the efficiency of stays in intensive care units (ICUs). Design: Prospective study. Setting: Seven ICUs of teaching hospitals in the Paris area. Patients: Two hundred eleven stays including one in three consecutive patients admitted from September to November 1996. Measurements and main results: For each patient, the following information was collected during the ICU stay: diagnosis, severity scores, organ failures, workload, cost and mortality. A cost-effectiveness ratio was computed for 176 stays with at least one organ failure, at hospital discharge and 6 months later. Quality of life was measured with EuroQol questionnaires 6 months after discharge in 64 patients representing 62% of the patients contacted. The mean total ICU cost per stay was US$ 14,130 (±6,550) (higher for non-survivors – US$ 19,060, median 10,590 – than for survivors – US$ 12,370, median 5,780). The incremental cost-effectiveness ratio was US$ 1,150 per life-year saved and the incremental cost-utility ratio was US$ 4,100 per quality-adjusted life-year (QALY) saved, without discounting. These results compare favourably with other health-care options. However substantial variations were observed according to age, severity, diagnosis, number of organ failures and discount rate. Intoxication had the lowest ratio (US$ 620/QALY) and acute renal insufficiency the highest (US$ 30,625/QALY). Conclusions: This work provides medical and economic information on ICU stays in teaching hospitals and enables comparisons with other health-care options.

[1]  H. Glick,et al.  Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. , 1995, Journal of neurosurgery.

[2]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[3]  A J Moskowitz,et al.  Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. , 1997, JAMA.

[4]  C. Sirio,et al.  Use of intensive care units for patients with low severity of illness. , 1998, Archives of internal medicine.

[5]  M Gyldmark,et al.  A review of cost studies of intensive care units: problems with the cost concept. , 1995, Critical care medicine.

[6]  G. Raghu,et al.  The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. , 1995, Chest.

[7]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[8]  S. Ridley,et al.  A cost‐utility analysis of intensive therapy , 1994, Anaesthesia.

[9]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .

[10]  T. Clemmer,et al.  Prolonged mechanical ventilation for respiratory failure: A cost‐benefit analysis , 1983, Critical care medicine.

[11]  T. Noseworthy,et al.  Cost accounting of adult intensive care: methods and human and capital inputs. , 1996, Critical care medicine.

[12]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .

[13]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[14]  R. Jackson,et al.  Long term survival after intensive care. , 1990, BMJ.

[15]  D. Elliott.  Costing intensive care services: a review of study methods, results and limitations. , 1997, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[16]  S. Lemeshow,et al.  Intensive care unit patient follow-up. Mortality, functional status, and return to work at six months. , 1989, Archives of internal medicine.

[17]  F. Saulnier,et al.  Quality of life 6 months after intensive care: results of a prospective multicenter study using a generic health status scale and a satisfaction scale , 1997, Intensive Care Medicine.

[18]  Paul Kind,et al.  Variations in population health status: results from a United Kingdom national questionnaire survey , 1998, BMJ.

[19]  M. Delgado-Rodríguez,et al.  Factors related to quality of life 12 months after discharge from an intensive care unit , 1992, Critical care medicine.

[20]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine , 1997 .

[21]  B. Guidet,et al.  [Organization and quality control of a clinical database on intensive care medicine in central and suburban Paris]. , 1998, Revue d'epidemiologie et de sante publique.

[22]  K. Hillman,et al.  The Use of “Quality-Adjusted Life Years” (QALYs) to Evaluate Treatment in Intensive Care , 1995, Anaesthesia and intensive care.

[23]  G. Rosenthal,et al.  An evaluation of the impact of nonresponse bias on patient satisfaction surveys. , 1997, Medical care.

[24]  J. Olsen,et al.  Treatment costs in Hodgkin's disease: a cost-utility analysis. , 1996, European journal of cancer.

[25]  A Gafni,et al.  clinical investigations incritical care IsIt'Worthwhile' ToContinue Treating Patients Witha Prolonged Stay (>14 Days) in , 2015 .